{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:37:03Z","timestamp":1792633023415,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016724","name":"Postgraduate Institute of Medical Education and Research, Chandigarh","doi-asserted-by":"publisher","award":["71\/2-EDU-16\/1160 , IM\/13\/09-12-21-0160"],"award-info":[{"award-number":["71\/2-EDU-16\/1160 , IM\/13\/09-12-21-0160"]}],"id":[{"id":"10.13039\/100016724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Isolating circulating tumour cells (CTCs) from the blood is challenging due to their low abundance and heterogeneity. Limitations of conventional CTC detection methods highlight the need for improved strategies to detect and isolate CTCs. Currently, the Food and Drug Administration (FDA)-approved CellSearch\u2122 and other RUO techniques are not available in India. Therefore, we wanted to develop a flexible CTC detection\/isolation technique that addresses the limitation(s) of currently available techniques and is suitable for various downstream applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed a novel, efficient, user-friendly CTC isolation strategy combining density gradient centrifugation and immuno-magnetic hematogenous cell depletion with fluorescence-activated cell sorting (FACS)-based positive selection using multiple CTC-specific cell-surface markers. For FACS, a stringent gating strategy was optimised to exclude debris and doublets by side scatter\/forward scatter (SSC\/FSC) discriminator, remove dead cells by 4\u2032,6-diamidino-2-phenylindole (DAPI) staining, and eliminate non-specific fluorescence using a \u201cdump\u201d channel. APC-labelled anti-CD45mAB was used to gate remaining hematogenous cells, while multiple epithelial markers (EpCAM, EGFR, and Pan-Cytokeratin) and an epithelial\u2013mesenchymal transition (EMT) marker (Vimentin) labelled with fluorescein isothiocyanate (FITC) were used to sort cancer cells. The technique was initially developed by spiking Cal 27 cancer cells into the blood of healthy donors and then validated in 95 biopsy-proven oral squamous cell carcinoma (OSCC) patients. CTCs isolated from patients were reconfirmed by Giemsa staining, immuno-staining, and whole transcriptome amplification (WTA), followed by qRT-PCR.\n                      <jats:italic>In vitro<\/jats:italic>\n                      culture and RNA sequencing (RNA-Seq) were also performed to confirm their suitability for various downstream applications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean detection efficiency for the Cal 27 tongue cancer cells spiked in the whole blood of healthy donors was 32.82% \u00b1 12.71%. While ~75% of our patients (71\/95) had detectable CTCs, the CTC positivity was independent of the TNM staging. The isolated potential cancer cells from OSCC patients were heterogeneous in size. They expressed different CTC-specific markers in various combinations as identified by qRT-PCR after WTA in different patients. Isolated CTCs were also found to be suitable for downstream applications like short-term CTC culture and RNA-Seq.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed a sensitive, specific, flexible, and affordable CTC detection\/isolation technique, which is scalable to larger patient cohorts, provides a snapshot of CTC heterogeneity, isolates live CTCs ready for downstream molecular analysis, and, most importantly, is suitable for developing countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2024.1269211","type":"journal-article","created":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T23:28:56Z","timestamp":1708903736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Anshika","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta S.","family":"Boora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monil","family":"Parsana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimanti","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2664","article-title":"Circulating tumor cells: a multifunctional biomarker","volume":"20","author":"Yap","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"104237","DOI":"10.1016\/j.ebiom.2022.104237","article-title":"Circulating tumor cell isolation for cancer diagnosis and prognosis","volume":"83","author":"Deng","year":"2022","journal-title":"EBioMedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/cells9081836","article-title":"Epithelial cell adhesion molecule: an anchor to isolate clinically relevant circulating tumor cells","volume":"9","author":"Eslami","year":"2020","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-016-1500-6","article-title":"Epithelial-mesenchymal plasticity in circulating tumor cells","volume":"95","author":"Alix-Panabi\u00e8res","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v7i17","article-title":"Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer","volume":"7","author":"Hyun","year":"2016","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/bit.22066","article-title":"Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells","volume":"102","author":"Yang","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061774","article-title":"Filtration parameters influencing circulating tumor cell enrichment from whole blood","volume":"8","author":"Coumans","year":"2013","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2017.11.026","article-title":"High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method","volume":"102","author":"Sun","year":"2018","journal-title":"Biosens Bioelectron"},{"key":"B9","doi-asserted-by":"publisher","first-page":"105636","DOI":"10.1016\/j.oraloncology.2021.105636","article-title":"Potential prognostic and predictive role of baseline circulating tumor cells in head and neck squamous cell carcinoma","volume":"124","author":"Chauhan","year":"2022","journal-title":"Oral Oncol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.oooo.2022.02.018","article-title":"Circulating tumor cells as a predictor for poor prognostic factors and overall survival in treatment na\u00efve oral squamous cell carcinoma patients","volume":"134","author":"Qayyumi","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3332\/ecancer.2023.1578","article-title":"Role of circulating tumour cells (CTCs) in recurrent\/metastatic head and neck squamous cell carcinoma (HNSCC)","volume":"17","author":"Baa","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2013a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/1-59259-969-9:29","article-title":"Serial biopsies\/fine-needle aspirates and their assessment","volume":"120","author":"Boeddinghaus","year":"2006","journal-title":"Methods Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr","article-title":"Cons: Can liquid biopsy replace tissue biopsy","volume":"5","author":"Mino-Kenudson","year":"2016","journal-title":"-the US experience Transl Lung Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.21037\/atm","article-title":"A narrative review of tumor heterogeneity and challenges to tumor drug therapy","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann Transl Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-020-00923-4","article-title":"Exploration of circulating tumour cell (CTC) biology: A paradigm shift in liquid biopsy","volume":"36","author":"Chauhan","year":"2021","journal-title":"Indian J Clin Biochem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.07.044","article-title":"CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients","volume":"46","author":"Sun","year":"2019","journal-title":"EBioMedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1158\/1541-7786.MCR-10-0490","article-title":"Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers","volume":"9","author":"Armstrong","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.405","article-title":"Detection of circulating tumour cells with a hybrid (epithelial\/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer","volume":"105","author":"Lecharpentier","year":"2011","journal-title":"Br J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128180","article-title":"Sensitive and easy screening for circulating tumor cells by flow cytometry","volume":"5","author":"Lopresti","year":"2019","journal-title":"JCI Insight"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.540","article-title":"A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer","volume":"31","author":"Bonnomet","year":"2012","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13058-016-0687-3","article-title":"In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis","volume":"18","author":"Bulfoni","year":"2016","journal-title":"Breast Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/gad.305805.117","article-title":"A conduit to metastasis: circulating tumor cell biology","volume":"31","author":"Micalizzi","year":"2017","journal-title":"Genes Dev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2017.01.026","article-title":"SnapShot: circulating tumor cells","volume":"168","author":"Dive","year":"2017","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jamcollsurg.2015.05.014","article-title":"Circulating epithelial cells in patients with pancreatic lesions: clinical and pathologic findings","volume":"221","author":"Cauley","year":"2015","journal-title":"J Am Coll Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<8::AID-IJC2>3.0.CO;2-K","article-title":"Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease","volume":"89","author":"Hardingham","year":"2000","journal-title":"Int J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30007","article-title":"A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells","volume":"138","author":"Hvichia","year":"2016","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012517","article-title":"Molecular biomarker analyses using circulating tumor cells","volume":"5","author":"Punnoose","year":"2010","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.13367","article-title":"Mutational analysis of circulating tumor cells using a novel microfluidic collection device and qPCR assay","volume":"6","author":"Harb","year":"2013","journal-title":"Transl Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1159\/000485115","article-title":"A comparison of three methods for the detection of circulating tumor cells in patients with early and metastatic breast cancer","volume":"44","author":"Politaki","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"252361","DOI":"10.1155\/2011\/252361","article-title":"Detection of epCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood","volume":"2011","author":"Mikolajczyk","year":"2011","journal-title":"J Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241123","article-title":"Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization","volume":"15","author":"Cohen","year":"2020","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr130","article-title":"The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)","volume":"22","author":"Hristozova","year":"2011","journal-title":"Ann Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.02.009","article-title":"Monitoring of circulating tumor cells and their expression of EGFR\/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck","volume":"83","author":"Tinhofer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-013-2399-y","article-title":"Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma","volume":"270","author":"Bozec","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.05.007","article-title":"Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival","volume":"48","author":"Buglione","year":"2012","journal-title":"Eur J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215113001412","article-title":"Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results","volume":"127","author":"He","year":"2013","journal-title":"J Laryngol Otol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21941","article-title":"Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system","volume":"34","author":"Nichols","year":"2012","journal-title":"Head Neck"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1269211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T23:29:00Z","timestamp":1708903740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1269211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":39,"alternative-id":["10.3389\/fonc.2024.1269211"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1269211","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"article-number":"1269211"}}